貝克微(02149.HK)202年度盈利達1.67億元 同比增長52.6%
格隆匯3月20日丨貝克微(02149.HK)公佈年度業績,截至2024年12月31日止年度,公司收入爲人民幣5.79億元,同比增長24.8%;毛利爲人民幣3.07億元,同比增長19.4%;年內利潤爲人民幣1.67億元,同比增長52.6%,基本每股收益爲人民幣2.78元。
收入增長主要得益於基於機器學習的半自動化芯片設計方法的優化、工業類新產品的持續推出、重要客戶的深度拓展等。由於公司向客戶提供小批量多品種產品,毛利及毛利率很大程度上取決於產品組合的變化。公司2024年銷售收入與毛利均有所增長,同時由於不同毛利率產品銷售額的不同,使得毛利率略有變化。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.